Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Laurantis Pharma Oy”

1 pharma patents match "Laurantis Pharma Oy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 1 pharmaceutical patents matching "Laurantis Pharma Oy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1 result for “Laurantis Pharma Oy” · 30,257 patents in full index Clear search

  1. US 8852936

    Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

    Laurantis Pharma Oy · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.